Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cardiovascular disease; Hypertension; Cost-effectiveness analysis;
مقالات ISI تجزیه و تحلیل هزینه-اثربخشی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cost-effectiveness analysis; Human resource constraints; Decision rules; Health care input constraints; Opportunity costs; Eye-care services; LMIC;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Radon; Cost-effectiveness analysis; Lung cancer; Prevention;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Becker; cost-effectiveness analysis; Duchenne; economic evaluation; immunohistochemistry; MLPA; muscular dystrophy; PCR; sequencing; Western blot;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Non small cell lung cancer; Cost-effectiveness analysis; Stereotactic body radiotherapy; Lobectomy;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; colorectal cancer screening; cost-effectiveness analysis; patient navigation; social inequalities;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; combination therapy; cost-effectiveness analysis; hepatocellular carcinoma; monotherapy; sorafenib;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Influenza; Vaccination; Mathematical model; Cost-effectiveness analysis; Simulation;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Breast neoplasm; Mass screening; Mammography; Age; Cost-effectiveness analysis; Computer simulation;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cervical cancer; Mass screening; Cost-effectiveness analysis; Mathematical model; Human papillomavirus;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; automated assessment; cost-effectiveness analysis; cost-utility analysis; depression; direct health care costs; disease management; health technology assessment; primary care; telemedicine;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; drug cost; health economic methods; United States;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; cost-effectiveness threshold; ICER; Irish health care; waiting list;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Environmental Management; Cost-effectiveness Analysis; Invasive Species; Willingness to Pay; Funding; Island Conservation;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; emergency contraception; incremental cost-effectiveness ratio; intrauterine device;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cost-effectiveness analysis; Budget impact analysis; Diagnosis; Ovarian cancer; Ultrasound; RMI; subjective assessment; Simple ultrasound-based rules; LR2 model; ADNEX model;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost; cost-effectiveness analysis; discrete event simulation; economic evaluation; follicular lymphoma; patient level simulation;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Bovine tuberculosis; Mycobacterium bovis; Targeted surveillance; Disease spread; Cattle movements; Cost-effectiveness analysis;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Asthma; Cost; Effectiveness; Cost-effectiveness; Cost-benefit; Review; CEA; Cost-effectiveness analysis; ED; Emergency department; GDP; Gross domestic product; HRQOL; Health-related quality of life; NIH; National Institutes for Health; WTP; Willingness to
Keywords: تجزیه و تحلیل هزینه-اثربخشی; constrained optimization modeling; cost-effectiveness analysis; fiscal health modeling; vaccination program;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Lung neoplasms; Canada; Cost-effectiveness analysis; Net monetary benefit;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Health technology assessment; Decision making; Cost-effectiveness analysis; Ethics; Decision analysis;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; ACDF; Anterior cervical discectomy and fusion; CDR; Cervical disc replacement; Cervical spine; Cost-effectiveness Analysis; Degenerative disc disease; Spine surgery;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Back pain; Cost; Cost-effectiveness analysis; Decompression surgery; Interspinous spacer device; Lumbar spine; Medicare; Reoperation; Spinal stenosis; Spine surgery;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cost-effectiveness analysis; Amalgam; Glass ionomer cement; Atraumatic restorative treatment; Primary teeth; Restorations; Treatment time; Cost;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Early detection; LDCT screening; Health economic evaluation; Cost-effectiveness analysis; Markov modelling; Bayesian calibration;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Influenza; Cost-effectiveness analysis; Herd immunity; Dynamic model;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost; cost-effectiveness analysis; value frameworks; value of knowing;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Wounds; Surgical site infection; Negative pressure wound therapy; Caesarean section; Cost-effectiveness analysis; NHMRC; National Health and Medical Research Council; NPWT; Negative Pressure Wound Therapy; SSI; Surgical Site Infection; QALY; Quality-Adjus
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cost-effectiveness analysis; Simmulation; HAI;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; budget impact analysis; cost-effectiveness analysis; health care decision making; health economics; health technology assessment; pharmacoeconomic model;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Colombia; cost-effectiveness analysis; diabetes; dulaglutide; insulin glargine; liraglutide; quality-adjusted life-years;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; High dose influenza vaccine; Cost-effectiveness analysis; Influenza vaccination policy; SD-IIV3; standard-dose trivalent inactivated influenza vaccine; HD-IIV3; high-dose trivalent inactivated influenza vaccine; RIV; recombinant trivalent influenza vaccin
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; delivery of health care; health equity; technology assessment;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; healthcare costs; oncology treatments; value frameworks;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; review; pathology testing; economic evaluation;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; health benefits package; universal health coverage;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; advanced pancreatic cancer; Bayesian network meta-analysis; chemotherapy; cost-effectiveness analysis; economic evaluation; gemcitabine;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; cost-effectiveness analysis; discount; guideline; productivity loss; QALY;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; H43; Q38; Q42; Recycling; Incineration; Plastic waste; Cost-effectiveness analysis;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Human papillomavirus; Vaccination; Men who have sex with men; Mathematical modelling; Cost-effectiveness analysis;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; bariatric surgery; cost-effectiveness analysis; diabetes mellitus; obesity;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; The Netherlands; Contingent valuation; Patients' time; Monetary valuation; Economic evaluations; Willingness to pay; Cost-effectiveness analysis;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Fibrilación auricular; Ictus; Tratamiento anticoagulante; Análisis de costo-efectividad; Atrial fibrillation; Stroke; Anticoagulation therapy; Cost-effectiveness analysis;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; breast cancer; cost-effectiveness analysis; mass screening; microsimulation;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Peanut oral immunotherapy; Cost-effectiveness analysis; FAQL-PF; Food Allergy Quality of Life-Parent Form; ICER; Incremental cost-effectiveness ratio; OIT; Oral immunotherapy; POIT; Peanut oral immunotherapy; QALY; Quality-adjusted life-year; QOL; Quality
Keywords: تجزیه و تحلیل هزینه-اثربخشی; breast cancer; cost-effectiveness analysis; discrete event simulation; screening;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Marine recreational fishing; Monitoring; Cost-effectiveness analysis; Fisheries management;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Cost-effectiveness analysis; Cost-utility analysis; Economic evaluation; Pancreatic ductal adenocarcinoma; Quality-adjusted life years;
Keywords: تجزیه و تحلیل هزینه-اثربخشی; Monetary conversion factors; Economic evaluation; Cost-effectiveness analysis; Cost-benefit analysis; Substance use disorders; Economic consequences;